The Patent Finder

Thrombolytic Science, LLC

Also on record
Records under this name other than the patents Thrombolytic Science, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 4 of 4 · Back to Thrombolytic Science, LLC

PatentTitleStatus Expires Confidence
US 7,837,992C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
Formerly held
In force
Term ended Oct 30, 2026 · From the USPTO record
In forceTerm ended Oct 30, 2026From the USPTO record
US 8,187,592C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
Term ended
Term ended Jul 9, 2026 · From the USPTO record
Term endedTerm ended Jul 9, 2026From the USPTO record
US 7,070,958Methods of making pro-urokinase mutants
Term ended
Term ended Jul 13, 2024 · From the USPTO record
Term endedTerm ended Jul 13, 2024From the USPTO record
US 7,074,401Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
Term ended
Term ended May 25, 2024 · From the USPTO record
Term endedTerm ended May 25, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited